B

Beijing Succeeder Technology Inc
SSE:688338

Watchlist Manager
Beijing Succeeder Technology Inc
SSE:688338
Watchlist
Price: 32.11 CNY 7.46% Market Closed
Market Cap: ¥3.4B

Beijing Succeeder Technology Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Beijing Succeeder Technology Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Succeeder Technology Inc
SSE:688338
Free Cash Flow
¥50.6m
CAGR 3-Years
-18%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
S
Shanghai Conant Optical Co Ltd
HKEX:2276
Free Cash Flow
¥261.8m
CAGR 3-Years
59%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Free Cash Flow
¥731.2m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Free Cash Flow
¥364.9m
CAGR 3-Years
42%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Free Cash Flow
¥917.2m
CAGR 3-Years
29%
CAGR 5-Years
13%
CAGR 10-Years
23%
Intco Medical Technology Co Ltd
SZSE:300677
Free Cash Flow
-¥1B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Beijing Succeeder Technology Inc
Glance View

Market Cap
3.4B CNY
Industry
Health Care

Beijing Succeeder Technology, Inc. engages in research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company is headquartered in Beijing, Beijing and currently employs 266 full-time employees. The company went IPO on 2020-08-06. The firm provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The firm operates its businesses within the domestic market and to overseas markets.

Intrinsic Value
27.99 CNY
Overvaluation 13%
Intrinsic Value
Price ¥32.11
B

See Also

What is Beijing Succeeder Technology Inc's Free Cash Flow?
Free Cash Flow
50.6m CNY

Based on the financial report for Dec 31, 2024, Beijing Succeeder Technology Inc's Free Cash Flow amounts to 50.6m CNY.

What is Beijing Succeeder Technology Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-2%

The average annual Free Cash Flow growth rates for Beijing Succeeder Technology Inc have been -18% over the past three years , -2% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett